採用

Brand and Customer Manager Oncology
LVA - Riga - Rīga; LTU - Vilnius - Vilnius
·
On-site
·
Full-time
·
2d ago
Job Description:
Company is seeking a dynamic and strategic Brand & Customer Manager (BCM) to lead brand growth initiatives and customer engagement across Lithuania, Latvia, and Estonia. The BCM will play a pivotal role in identifying growth opportunities, setting portfolio priorities, and developing robust business plans aligned with both global and local strategies.
As the BCM, you will design, develop, and implement targeted marketing programs for oncology brands and portfolios, ensuring launch excellence and ongoing optimization of existing products. You will collaborate closely with the Business Unit Director Oncology and Medical Team to deliver exceptional customer experiences and strengthen company’s position as a trusted partner within the oncology community.
Key Responsibilities
-
Identify and capitalize on brand growth opportunities within the Baltic oncology market.
-
Develop and execute comprehensive marketing strategies and media plans consistent with global and local directives.
-
Prepare and ensure launch readiness for new oncology products in assigned countries.
-
Drive and optimize existing oncology business performance.
-
Engage with top-tier customers, including healthcare professionals and payers, to improve patient health outcomes.
-
Collaborate cross-functionally with internal teams to deliver value to patients, payers, and physicians.
-
Manage brand budgets, sales forecasts, and financial planning to support business objectives.
-
Utilize omnichannel marketing approaches to maximize brand reach and impact.
-
Lead projects and initiatives within a matrix organizational structure, influencing without direct authority.
-
Represent company at industry events and conferences as needed.
Education, Experience & Competencies
-
Bachelor’s or Master’s degree in Life Sciences preferred; additional business education is a strong advantage.
-
Minimum 5 years of experience in the pharmaceutical industry, preferably within oncology.
-
Proven ability to manage key external stakeholders and influence cross-functional teams.
-
Strong leadership, problem-solving, project management, and communication skills.
-
Effective team player with the ability to listen and integrate diverse perspectives.
-
Solid knowledge of financial management including brand budgeting and sales forecasting.
-
Business acumen with awareness of industry policies, trends, and technologies.
-
Skilled in prioritizing objectives and making resource allocation decisions.
-
Experience in omnichannel marketing strategies and execution.
-
Operational excellence with a track record of timely project delivery.
-
Proficient in MS Office and AI tools.
-
Fluent in English and either Lithuanian or Latvian.
-
Deep understanding of Baltic cultures and healthcare systems.
What We Offer
-
Opportunity to work with a leading global pharmaceutical company in a critical therapeutic area.
-
Collaborative and innovative work environment.
-
Hybrid working model with flexibility.
-
Competitive salary and benefits package.
-
Professional development and career growth opportunities.
-
Meaningful work impacting patient lives across the Baltic region.
How to Apply?
If you are passionate about oncology and ready to make a difference in the Baltic healthcare landscape, we invite you to apply by submitting your CV and cover letter!
Required Skills:
Adaptability, Brand Management, Competitor Analysis, Content Creation, Customer Insights, Customer-Oriented, Data Analysis, Digital Marketing, Event Planning, Influencing Skills, Marketing, Market Research, Oncology Marketing, Product Management, Social Media Marketing, Strategic Thinking, Trade Association Management
Preferred Skills:
Current Employees apply HERE
Current Contingent Workers apply HERE
Search Firm Representatives Please Read Carefully
Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.
Employee Status:
Regular
Relocation:
No relocation
VISA Sponsorship:
No
Travel Requirements:
25%
Flexible Work Arrangements:
Hybrid
Shift:
Not Indicated
Valid Driving License:
Yes
Hazardous Material(s):
n/a
Job Posting End Date:
04/22/2026
**A job posting is effective until 11:59:59PM on the day BEFORE the listed job posting end date. Please ensure you apply to a job posting no later than the day BEFORE the job posting end date.
総閲覧数
0
応募クリック数
0
模擬応募者数
0
スクラップ
0
類似の求人
Merckについて

Merck
PublicMultinational pharmaceutical company.
10,001+
従業員数
Rahway
本社所在地
$208B
企業価値
レビュー
4.3
10件のレビュー
ワークライフバランス
4.0
報酬
3.5
企業文化
4.2
キャリア
3.8
経営陣
4.0
78%
友人に勧める
良い点
Supportive management and colleagues
Good work-life balance and flexibility
Excellent benefits and health plans
改善点
High-pressure and demanding work environment
Limited career advancement opportunities
Below-average pay for entry-level positions
給与レンジ
2,504件のデータ
Director
Director · Associate Director, D&A Strategy
1件のレポート
$176,890
年収総額
基本給
$153,800
ストック
-
ボーナス
-
$176,890
$176,890
面接体験
6件の面接
難易度
3.0
/ 5
期間
14-28週間
内定率
17%
体験
ポジティブ 0%
普通 67%
ネガティブ 33%
面接プロセス
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Background Check
6
Offer
よくある質問
Behavioral/STAR
Past Experience
Technical Knowledge
Culture Fit
Case Study
ニュース&話題
Merck Unveils First-in-Human Data for PD-1/VEGF Bispecific MK-2010 - Oncodaily
Oncodaily
News
·
1d ago
Does EU Approval Of ENFLONSIA Reshape The Bull Case For Merck’s Pipeline Story (MRK)? - Yahoo Finance
Yahoo Finance
News
·
2d ago
Better Pharma Dividend Stock: Novartis vs. Merck - The Motley Fool
The Motley Fool
News
·
2d ago
AACR: Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans - Fierce Biotech
Fierce Biotech
News
·
2d ago




